ACVP Veterinary Pathology common mistakes
ACVP Veterinary Pathology · Understand the traps and how to avoid them.
Committing to a single morphologic diagnosis before systematically listing and ranking the differentials that fit the lesion pattern.
The exam rewards pattern recognition, so candidates over-anchor on the first disease that comes to mind and stop reasoning; this is especially costly on case-based items with atypical presentations.
What to do instead
Adopt a fixed routine: describe lesion (location, distribution, process), generate at least three ranked differentials, then test each against signalment, gross pattern, and expected histologic features before selecting an answer.
Reading the signalment and history only after forming an impression from the lesion description.
Under time pressure candidates jump to the lesion, but species, age, sex, and husbandry often eliminate most differentials and are the discriminator the item writer built in.
What to do instead
Make a deliberate first pass that extracts species, age, sex, and key history into a mental (or scratch) line before evaluating lesion morphology.
Describing lesions with vague terms (e.g., 'inflammation', 'degeneration') instead of specifying process, distribution, and severity in the required format.
Trained to think diagnostically rather than descriptively, candidates skip the descriptive step, and morphologic-diagnosis items are graded on the correct process plus qualifiers.
What to do instead
Practice writing morphologic diagnoses in a strict template (process + modifier + organ + distribution + chronicity) and self-check each component is present.
Misclassifying the primary tissue reaction (e.g., calling a neoplasm inflammatory, or a hyperplastic process neoplastic) because only the most eye-catching feature is weighed.
Mixed or secondary changes (necrosis, inflammation, hemorrhage) obscure the primary process, and candidates weight the most visually dramatic feature.
What to do instead
Identify the dominant process at low power first, then verify with high-power criteria (cellular atypia, architecture, cell of origin) before naming a diagnosis.
Selecting a tumor diagnosis without confirming the cell of origin and behavior from histologic criteria.
Candidates rely on gross appearance or a remembered 'classic' association and skip the criteria (e.g., anaplasia, invasion, mitotic rate) that distinguish benign from malignant and epithelial from mesenchymal.
What to do instead
For every neoplasm item, explicitly state the cell of origin, the benign/malignant criteria observed, and the margin/behavior evidence before answering.
Ignoring species-specific disease prevalence when ranking differentials (e.g., favoring a disease common in dogs for a feline or bovine case).
Candidates default to the species they see most often in training and apply that prior to all cases.
What to do instead
Keep a mental species-prevalence checklist (common vs. rare entities by species) and down-rank differentials that are epidemiologically implausible for the species and age.
Interpreting a single abnormal lab value in isolation without integrating the rest of the CBC/chemistry panel and the clinical context.
Each value looks abnormal in isolation, and candidates react to the flagged number rather than the pattern (e.g., the combination that indicates regeneration, hemolysis, or an artifact).
What to do instead
Read panels as patterns: assess erythron, leukon, and organ values together, and check whether abnormalities are consistent with one process or suggest artifact/preanalytical error.
Failing to distinguish preanalytical and analytical artifacts (e.g., hemolysis, lipemia, EDTA or clot effects, storage changes) from true pathologic findings.
Candidates assume every reported value reflects the patient and do not routinely consider sample handling, which is a common discriminator in clinical pathology items.
What to do instead
Before interpreting any abnormal value, run a standard artifact checklist (sample type, hemolysis/lipemia index, storage time, clot presence) and only then attribute findings to disease.
Misreading blood smear morphology-misidentifying cell lineage or missing toxic change, inclusions, or rouleaux-because of poor scan technique.
Candidates focus on the first field or the most numerous cells and skip the systematic low- and high-power scan needed to find diagnostic features.
What to do instead
Use a fixed smear routine: low-power scan for cellularity and clumps, then a defined number of high-power fields assessing leukocyte morphology, platelet estimate, and RBC morphology in order.
Choosing a cytologic interpretation without weighing the sampling limitations (blood contamination, low cellularity, poor preservation) that make a definitive diagnosis unsafe.
Candidates want to commit to a diagnosis and treat a nondiagnostic or hemodiluted sample as if it were representative.
What to do instead
State the adequacy of the sample first, then interpret only features supported by adequate cellularity and preservation; when criteria are insufficient, select the 'nondiagnostic/insufficient' or descriptive option rather than a definitive one.